A Gait Tracker to Train REEV's AI-Driven Exoskeleton for Neurological Gait Disorders

Project Coordinator
Amaury Ciurana,
Sacha Clauzade

Amaury Ciurana, CEO of REEV, has worked with the MIT Center for Clinical and Translational Research (CCTR) to evaluate the accuracy of REEV's gait analysis sensors. These devices are crucial for developing DREEVEN, their latest robotic knee brace. Targeting the 50 million stroke survivors with walking difficulties, REEV has introduced a cutting-edge, motorized, active brace. Powered by advanced machine learning algorithms, this brace aims to significantly aid in daily activities such as walking, standing, sitting, and climbing stairs. Additionally, REEV was recently honored as a recipient of the Massachusetts eHealth Institute (MeHI) award, recognizing their significant contributions to healthcare innovation and technology.

 

For its clinical development, REEV is comparing its gait tracking sensors against conventional gait analysis techniques, like those in motion capture labs. The study at the CCTR lab is focused on collecting and analyzing data from 20 participants affected by stroke.

Amaury Ciurana shared with us, “Working with the CCTR team has been an exceptional experience. Their dedication to top-notch research complements our goal to confirm the clinical efficacy of REEV SENSE. Our main aim is to deliver an improved version of our robotic knee brace to patients. This study not only allowed us to gather essential data to refine our device technically but also to gain valuable insights into the users' needs and how we can better support them at home.”

This study meticulously assessed a wide range of gait biomarkers, conducting an in-depth spatio-temporal gait analysis. Measurements included walking speed, cadence, step count, stride length, and the timing of swing and stance phases, as well as stance phase symmetry analysis. By attaching REEV SENSE to the patient's thigh, calf, or ankle, it accurately quantified joint movements, especially capturing knee and ankle flexion angles.

The study was planned and developed by the REEV team and with consultation with with the CCTR team, which includes Catherine E. Ricciardi, Director of Clinical and Research Operations, Tatiana Urman, Clinical Research Nurse and Research Coordinator, and Evan Linton, Clinical Research Technologist.

If you're interested in more information about this study and the product, or know someone who might be, please reach out to Amaury Ciurana at amaury.ciurana [at] reev.care.

Visit reev.care for more information.